PATENT CLAIM ANALYSIS

Application Number: 15899895
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["435", "325000"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 13):
The enucleated erythroid cell of  claim 1 , which exhibits an increase in uricase activity of at least 2-fold relative to that of an enucleated erythroid cell that does not comprise the first exogenous polypeptide.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.44444
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15824877', '15783921', '15473421', '14738414', '15716141']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7069878310393019
- 35 USC 102 Novelty (BERT): 0.5928117001874897
- Combined Prediction Score: 0.6955702179541207
- Mean Citation Score: 512.9859120000001
- Max Citation Score: 580.7952
- Similarity Product: 418.4279036602021

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test